PROM1 and neoplasm: FX-11, an inhibitor of lactic acid production, inhibited liver tumor propagation (Fig. 4E and Supplementary Fig. 7A), decreased the ratios of CD133+ liver TICs (Fig. 4F), and impaired the tumor initiation capacity (Fig. 4G), indicating that lactic acid was a driver of liver TIC self-renewal.